Kidney patients needed for pain drug study
NCT ID NCT07189962
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This completed Phase 1 study looked at how the drug SHR8554 injection behaves in 20 people with kidney problems compared to healthy volunteers. The goal was to measure drug levels and safety, not to treat pain. Results will help guide future dosing for patients with kidney issues.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- SHR8554 injection
- What this could lead to
- If successful, this could help doctors understand how to dose SHR8554 safely for people with kidney problems.
- What could go wrong
- This is a very early, small study (20 people) focused on drug levels, not on treating pain. It may not lead to any new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE TO SEVERE POSTOPERATIVE PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Affiliated Hospital of Qingdao University
Qingdao, Shandong, 266003, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- What does life feel like for children with a rare birth defect? a new study asks
- Kidney health may change how this drug works
- Heat wave warning: study reveals how chronic illness patients suffer in high temperatures
- Kidney function may change how diabetes drug works
- Dialysis patients wear heart monitors for a week to uncover hidden risks
- New combo therapy could protect kidneys and hearts without High-Dose statins